HealthQuill Medical
Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European Union, the companies announced.
Drugs Medical Pharma

EU green lights AstraZeneca, Daiichi’s treatment for breast cancer

HQ Team April 4, 2025: Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European.

Read More
Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and Drug Administration, according to a statement.
Drugs Health Medical

Amgen gets US approval to treat immunoglobulin G4-related disease 

HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.

Read More
Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development assistance (ODA) — a barometer for international aid flow, according to a concept paper from the Africa Centres for Disease Control and Prevention.
Climate Health Medical

Africa’s health sector facing ‘unprecedented’ financial crisis: CDC

HQ Team April 4, 2025: Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development.

Read More
The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating dry eyes, over concerns with the data from the trial.
Drugs Health Medical

Aldeyra Therapeutics’ dry eye treatment rejected by USFDA

HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.

Read More
Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according to a UN official.
Drugs Health Medical

Sudan heading for famine as fighting ravages Darfur, UN warns

HQ Team April 2, 2025: Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according.

Read More
Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from Biogen Inc., for an undisclosed amount.
Drugs Medical Pharma

Organon & Co. buys biosimilar from Biogen for an undisclosed sum

HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from.

Read More
The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in adult women and girls above 12 years, according to the company.
Drugs Medical Pharma

GSK’s drug to fight urinary tract infections gets USFDA approval

HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in.

Read More
The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that is designed to detect Pseudomonas infections from a person’s breath.
Drugs Health Medical

CF Foundation to fund project to find lung infections from people’s breath

HQ Team March 26, 2025: The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that.

Read More
The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems at a time when up to 90% of the people in some nations with severe mental health conditions receive no care at all.
Health Medical Pharma

WHO unveils new guidelines to tackle mental health systems, policies

HQ Team March 26, 2025: The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems.

Read More
Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and commercialising of the Chinese company’s “triple G” weight-loss candidate.
Drugs Medical Pharma

Novo Nordisk in $2b deal with Chinese firm for ‘triple-G’ obesity drug

HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.

Read More